Answer
Sandostatin (octreotide acetate) solution for injection/infusion is contraindicated in patients with known hypersensitivity to octreotide acetate or any excipient listed in section 6.1.
Sources for this answer
- Sandostatin 50, 100, 500 microgram/1 ml solution for injection/infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.3 Contraindications · Version 27Document updated
Sources checked